Reprotech's TMRW Vault Receives CE Marking Under MDR Regulation
Reprotech announced that its TMRW Vault has received CE marking as a Class IIa medical device under the EU's MDR regulation. This certification enables commercialization within the European Union and other international markets.
Wilmington, Delaware – July 7, 2026 – Reprotech announced today that its TMRW Vault® has received CE marking as a Class IIa medical device. This certification aligns with the European Union's Medical Device Regulation (MDR) 2017/745.
The CE marking is a prerequisite for the device's commercialization within the European Economic Area and also permits broader international distribution. The TMRW Vault is intended for applications such as biobanking, offering solutions for cell material storage and management.
This regulatory clearance underscores Reprotech's commitment to stringent safety and quality standards. The process to obtain CE marking involves comprehensive documentation and demonstration of the device's clinical performance.
Data management and storage are critical areas in biotechnology and healthcare. Solutions like the TMRW Vault aim to ensure the integrity and traceability of biological samples.